Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240784 · ClinicalTrials.gov registry record
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
A clinical trial, sponsored by Alnylam Pharmaceuticals.
- Completed
- Registry status
- 136
- Enrollment target
NCT02240784 is a clinical trial that has completed, run by Alnylam Pharmaceuticals. The registered enrollment target is 136 participants.
The verdict
NCT02240784 has completed, sponsored by Alnylam Pharmaceuticals.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2014-08 |
| Est. Completion | 2021-04-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240784
The ClinicalTrials.gov registry entry for NCT02240784 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alnylam Pharmaceuticals, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02240784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02240784 about?
NCT02240784 is a clinical study titled "EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)". The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.
What is the current status of trial NCT02240784?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2014-08. Estimated completion is 2021-04-26.
Who is sponsoring clinical trial NCT02240784?
This trial is sponsored by Alnylam Pharmaceuticals, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.